Interventions in Chronic Pain Management. 5. Approaches to Medication and Lifestyle in Chronic Pain Syndromes

Archives of Physical Medicine and Rehabilitation

Volumn 89, Issue 3 SUPPL. 1, 2008, Pages

  Freedman, Mitchell K ^a   Saulino, Michael F ^b   Overton, E Anthony ^a   Holding, Michele Y ^c   Kornbluth, Ira D ^d  

^a ROTHMAN INSTITUTE   (United States)

^b Moss Rehabilitation   (United States)

^c The Back Pain Center   (United States)

^d Spine Medicine & Rehabilitation Therapies Westminster   (United States)

Author keywords

Complex regional pain syndrome; Low back pain; Obesity; Rehabilitation; Smoking cessation; Trigeminal neuralgia

Indexed keywords

ACETYLSALICYLIC ACID; CARISOPRODOL; CLONIDINE; CYCLOBENZAPRINE; DULOXETINE; ETIRACETAM; FELBAMATE; FENTANYL; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; METAXALONE; ORPHENADRINE; OXCARBAZEPINE; PREGABALIN; TIAGABINE; TOPIRAMATE; ZONISAMIDE; ANALGESIC AGENT;

ADULT; ARTICLE; CHRONIC PAIN; COMPLEX REGIONAL PAIN SYNDROME; FEMALE; HUMAN; LIFESTYLE; LOW BACK PAIN; OBESITY; RECOMMENDED DRUG DOSE; SMOKING CESSATION; TRIGEMINUS NEURALGIA; BEHAVIOR THERAPY; CHRONIC DISEASE; METHODOLOGY; PAIN; PSYCHOLOGICAL ASPECT; REVIEW;

ANALGESICS; BEHAVIOR THERAPY; CHRONIC DISEASE; HUMANS; LIFE STYLE; PAIN; SMOKING CESSATION;

EID: 42149158280     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2007.12.002     Document Type: Article

References (40)

1. Riebel G.D., Boden S.D., Whitesides T.E., and Hutton W.C. The effect of nicotine on incorporation of cancellous bone graft in an animal model. Spine 20 (1995) 2198-2202
2. Leboeuf-Yde C., Ohm Kyvik K., and Henrik Bruun N. Low back pain and lifestyle. Part I. Smoking information from a population-based sample of 29,424 twins. Spine 23 (1998) 2207-2214
3. Scott S.C., Goldberg M.S., Mayo N.E., Stock S.R., and Poitras B. The association between cigarette smoking and back pain in adults. Spine 24 (1999) 1090-1098
4. Kaila-Kangas L., Leio-Arjas P., Riihimk̈i H., Luukkonen E., and Kirjonen J. Smoking and overweight as predictors of hospitalization of back disorders. Spine 28 (2003) 1860-1868
5. Leboeuf-Yde C. Smoking and low back pain: a systematic literature review of 41 journal articles reporting 47 epidemiologic studies. Spine 24 (1999) 1463-1470
6. Silcox D.H., Daftari T., Boden S.D., Schimandle J.H., Hutton W.C., and Whitesides Jr. T.E. The effect of nicotine on spinal fusion. Spine 20 (1995) 1549-1553
7. Glassman S.D., Anagnost S.C., Parker A., Burke D., Johnson J.R., and Dimar J.R. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine 25 (2000) 2608-2615
8. Anderson T., Christensen F.B., Laursen M., Hoy K., Hansen E.S., and Bunger C. Smoking as a predictor of negative outcome in lumbar spinal fusion. Spine 26 (2001) 2623-2628
9. Henningfield J. Nicotine medication for smoking cessation. N Engl J Med 333 (1995) 1196-1203
10. Cahill K., Stead L., and Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 1 (2007) CD006103.
11. Sigaly C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3 (2004) CD000146.
12. Leboeuf-Yde C., Kyvik K.O., and Bruun N.H. Low back pain and lifestyle. Part II. Obesity. Information from a population-based sample of 29,424 twin subjects. Spine 24 (1999) 779-784
13. Pi-Sunyer F.X. The medial risks of obesity. Obes Surg 12 Suppl 1 (2002) 6S-11S
14. Marcus D. Obesity and the impact of chronic pain. Clin J Pain 63 (2004) 186-191
15. Mayer T., Aceska A., and Gatchel R.J. Is obesity overrated as a "risk factor" for poor outcomes in chronic occupational spinal disorders?. Spine 31 (2006) 2967-2972
16. Lake J., Power C., and Cole T.J. Back pain and obesity in the 1958 British birth cohort. Cause or effect?. J Clin Epidemiol 53 (2000) 245-250
17. Hill J.O., and Wyatt H.R. Role of physical activity in preventing and treating obesity. J Appl Physiol 99 (2005) 765-770
18. Stanton-Hicks M. Complex regional pain syndrome. Anesthesiol Clin North America 21 (2003) 733-744
19. Ribbers G.M., Geurts A.C., Stam H.J., and Mulder T. Pharmacologic treatment of complex regional pain syndrome I: a conceptual framework. Arch Phys Med Rehabil 84 (2003) 141-146
20. Stacey B.R. Management of peripheral pain. Am J Phys Med Rehabil 84 3 Suppl (2005) S4-S16
21. Howard P.A., and Delafontaine P. Nonsteroidal anti-inflammatory drugs and cardiovascular risk. J Am Coll Cardiol 43 (2004) 519-525
22. U.S. Food and Drug Administration. Concomitant use of ibuprofen and aspirin: potential for attenuation of the antiplatelet effect of aspirin (2006), FDA National Press Office, Rockville Sep.
23. Dugowson C.E., and Gnanashanmugam P. Nonsteroidal anti-inflammatory drugs. Phys Med Rehabil Clin N Am 17 (2006) 347-354
24. Kaplan R.J. Current status of nonsteroidal anti-inflammatory drugs in physiatry: balancing risks and benefits in pain management. Am J Phys Med Rehabil 84 (2005) 885-894
25. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 55 (2003) 1-20
26. Harden R.N. Pharmacotherapy of complex regional pain syndrome. Am J Phys Med Rehabil 84 (2005) S17-S28
27. Grabois M. Management of chronic low back pain. Am J Phys Med Rehabil 84 (2005) S29-S41
28. Chou R., Peterson K., and Helfand H. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 28 (2004) 140-147
29. Toth P.P., and Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 26 (2004) 1355-1367
30. Meleger A.L. Muscle relaxants and antispasticity agents. Phys Med Rehabil Clin N Am 17 (2006) 401-413
31. van de Vusse A.C., Stomp-van den Berg S.G., Kessels A.H., and Weber W.E. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1. BMC Neurol 4 (2004) 13
32. Wiffen P., Collins S., McQuay H., Carroll D., Jadad A., and Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 3 (2005) CD001133.
33. Bloodworth D. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations. Phys Med Rehabil Clin N Am 17 (2006) 355-379
34. Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil 84 (2005) S42-S55
35. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 3 (2005) CD005454.
36. Duhmke R.M., Cornblath D.D., and Hollingshead J.R. Tramadol for neuropathic pain. Cochrane Database Syst Rev 3 (2006) CD003726.
37. Crayton H., Heyman R.A., and Rossman H.S. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 63 11 Suppl 5 (2004) S12-S18
38. Schapiro R.T. Management of spasticity, pain and paroxysmal phenomena in multiple sclerosis. Curr Neurol Neurosci Rep 1 (2001) 299-302
39. Beard S., Hunn A., and Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess 7 (2003) iii, ix-x, 1-111.
40. Ehde D.M., Osborne T.L., and Jensen M.P. Chronic pain in persons with multiple sclerosis. Phys Med Rehabil Clin N Am 16 (2005) 503-512